Study Design and First Results of a Non-Interventional Registry Study To Establish Long-Term Safety and Pharmaco-Economic Data on Fingolimod (Gilenya®) in Multiple Sclerosis Patients in Germany (PANGAEA)

被引：0
|
作者：
Ziemssen, Tjalf [1 ]
van Lokven, Tom [2 ]
Kempke, Raimar [1 ]
Meergans, Matthias [2 ]
机构：
[1] Carl Gustav Carus Univ Hosp, Ctr Clin Neurosci, Dresden, Germany
[2] CNS Novartis Pharma GmbH, Clin Res, Nurnberg, Germany
来源：
NEUROLOGY | 2012年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P04131
引用
收藏
页数：2
相关论文
共 50 条
  • [31] 4 years PANGAEA: A 5-year non-interventional study of safety, effectiveness and pharmacoeconomic data for fingolimod patients in daily clinical practice - effectiveness update
    Ziemssen, T.
    Albrecht, H.
    Haas, J.
    Klotz, L.
    Lang, M.
    Lassek, C.
    Schmidt, S.
    Tackenberg, B.
    Cornelissen, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 417 - 417
  • [32] 4 Years PANGAEA: A 5-Year Non-Interventional Study of Safety, Effectiveness and Pharmacoeconomic Data for Fingolimod Patients in Daily Clinical Practice - Effectiveness Update
    Cornelissen, Christian
    Albrecht, Holger
    Haas, Judith
    Klotz, Luisa
    Lang, Michael
    Lassek, Chrstoph
    Schmidt, Stephan
    Tackenberg, Bjorn
    Ziemssen, Tjalf
    NEUROLOGY, 2016, 86
  • [33] Long-term safety of adalimumab in patients with moderate-to-severe ulcerative colitis: Interim results of a non-interventional registry, LEGACY
    Bossuyt, P.
    Atreya, R.
    Taxonera, C.
    Hebuterne, X.
    Isaacs, K.
    Higgins, P. D.
    Lindsay, J.
    Heap, G.
    Arikan, D.
    Kuehnl, V.
    Petersson, J.
    Robinson, A. M.
    Loftus, E. V., Jr.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S32 - S32
  • [34] Design of a non-interventional post-marketing study to assess the long-term safety and effectiveness of ocrelizumab in German real world multiple sclerosis cohorts - the CONFIDENCE study protocol
    Dirks, Petra
    Zingler, Vera
    Leemhuis, Jost
    Berthold, Heike
    Hieke-Schulz, Stefanie
    Wormser, David
    Ziemssen, Tjalf
    BMC NEUROLOGY, 2020, 20 (01)
  • [35] Design of a non-interventional post-marketing study to assess the long-term safety and effectiveness of ocrelizumab in German real world multiple sclerosis cohorts – the CONFIDENCE study protocol
    Petra Dirks
    Vera Zingler
    Jost Leemhuis
    Heike Berthold
    Stefanie Hieke-Schulz
    David Wormser
    Tjalf Ziemssen
    BMC Neurology, 20
  • [36] Long-Term Treatment of chronic schizophrenic Patients with Flupentixol decanoate Results of a prospective non-interventional Study
    Laux, Gerd
    Steinmann, Carsten
    Glaser, Thomas
    PSYCHOPHARMAKOTHERAPIE, 2010, 17 (06): : 274 - +
  • [37] Rationale, design, and methods of a non-interventional study to establish safety, effectiveness, quality of life, cognition, health-related and work capacity data on Alemtuzumab in multiple sclerosis patients in Germany (TREAT-MS)
    Tjalf Ziemssen
    Ulrich Engelmann
    Sigbert Jahn
    Alexandra Leptich
    Raimar Kern
    Lina Hassoun
    Katja Thomas
    BMC Neurology, 16
  • [38] Evaluation of Long-Term Safety of Latanoprost in Pediatric Populations: Design and Rationale of an Ongoing Non-Interventional Cohort Study
    Xu, Wanning
    Huang, Kui
    Sultan, Marla
    Zhang, Min
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 349 - 349
  • [39] Rationale, design, and methods of a non-interventional study to establish safety, effectiveness, quality of life, cognition, health-related and work capacity data on Alemtuzumab in multiple sclerosis patients in Germany (TREAT-MS)
    Ziemssen, Tjalf
    Engelmann, Ulrich
    Jahn, Sigbert
    Leptich, Alexandra
    Kern, Raimar
    Hassoun, Lina
    Thomas, Katja
    BMC NEUROLOGY, 2016, 16
  • [40] The safety and efficacy of fingolimod: Real-world data from a long-term, non-interventional study on the treatment of RRMS patients spanning up to 5 years from Hungary
    Biernacki, Tamas
    Sandi, Daniel
    Fuvesi, Judit
    Fricska-Nagy, Zsanett
    Kincses, Tamas Zsigmond
    Acs, Peter
    Rozsa, Csilla
    Dobos, Eniko
    Cseh, Botond
    Horvath, Laszlo
    Nagy, Zsuzsanna
    Csanyi, Attila
    Kovacs, Krisztina
    Csepany, Tunde
    Vecsei, Laszlo
    Bencsik, Krisztina
    PLOS ONE, 2022, 17 (04):
12345